Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer

Abstract

The authors developed a real-time and label-free approach based on quantitative phase imaging to determine drug sensitivity with significant advantages over endpoint viability or metabolic assays, and which reveals single cell response heterogeneity.